Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment With Everolimus in Second-Line Metastatic ccRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment With Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study)
Cancers (Basel) 2021 May 25;[EPub Ahead of Print], P Zeuschner, S Hölters, M Stöckle, B Seliger, A Mueller, HS Bachmann, V Grünwald, DC Christoph, A Stenzl, MO Grimm, F Brüning, PJ Goebell, M Augustin, F Roos, J Harde, I Benz-Rüd, M Staehler, K JunkerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.